Copenhagen, Denmark - A team of Danish researchers have shown that certain patients with congestive heart failure (CHF) may benefit from the class III antiarrhythmic drug dofetilide (Tikosyn? - Pfizer ...
Researchers have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. Researchers from Mayo Clinic and AliveCor Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback